Eugia Dexamethasone Injection Recall: Impurity Risk in Multiple-Dose Vials
Eugia US LLC recalls Dexamethasone Sodium Phosphate injection vials with impurity sulfonic acid adducts above specifications. Affected vials have specific lot numbers and expiration dates. Contact for remedy details.
“Eugia Dexamethasone Injection Recall: Impurity Risk in Multiple-Dose Vials.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32655-eugia-dexamethasone-injection-recall-impurity-risk-in-multiple-dose-vials. Based on FDA recall #D-0555-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0555-2024%22&limit=1).
Eugia US LLC recalled Dexamethasone Sodium Phosphate injection USP distributed by AuroMedics Pharma LLC nationwide due to failed impurity specifications, according to the FDA on May 23, 2024.
How to tell if you have it
Brand: Eugia
Product: Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial
NDC: 55150-239-30
Lot codes: 3DS23001, 3DS23004, 3DS23009, 3DS23011
Expiration dates: 6/30/2024 and 7/31/2024
Distribution: USA Nationwide
The hazard
The recall is due to impurity sulfonic acid adduct of dexamethasone phosphate results being above specification, according to the FDA.
Context
GovInfoNow's records show Eugia US LLC has 14 other recalls on record since December 28, 2022. Other recent recalls of similar products include Eugia's Lidocaine injection recall (May 18, 2026), Gentamicin Injection recall (May 29, 2025), and Tirofiban Injection recall (April 21, 2025). Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection recall (February 4, 2026), Sun Pharmaceutical Fluocinolone Acetonide Solution recall (December 30, 2025), and Sagent Busulfan Injection recall (May 4, 2026).
How to tell if you have this one
Check for lot numbers 3DS23001, 3DS23004 (expiring 6/30/2024) or 3DS23009, 3DS23011 (expiring 7/31/2024). The product is a prescription-only multiple-dose vial with 120mg per 30mL.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the lot number and expiration date on the vial label to confirm if it is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 34 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0555-2024 (May 23, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0555-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.